期刊文献+

抗中性粒细胞抗体相关性血管炎31例临床分析 被引量:2

Clinical characteristics of 31 patients with ANCA-associated vasculitis.
原文传递
导出
摘要 目的分析抗中性粒细胞抗体(ANCA)相关性血管炎(AAV)伴肾脏损害患者临床特征。方法收集2002年9月至2007年9月四川大学华西医院收治的31例临床诊断为AAV患者。间接免疫荧光及免疫酶联吸附试验(ELISA)均为ANCA阳性。逐项分析ANCA抗原谱,肾脏和肾外临床表现。结果本组AAV患者男16例,女15例。年龄18—84岁,平均(54.19±20.00)岁。显微镜下多血管炎(MPA)27例,韦格纳肉芽肿(WG)4例。肾脏症状首发16例,肾外症状首发15例,以呼吸系统症状首发者8例,8例伴咯血。27例MPA患者就诊时血肌酐平均(460.42±354.55)μmol/L。全组患者P—ANCA阳性24例,C-ANCA阳性7例,抗原识别抗MPO阳性25例。抗PR3阳性6例,抗BPI阳性3例。结论AAV临床表现多样,肺、肾是最常见的受累器官。本病晚期治疗方法十分有限.预后甚差.重视ANCA筛查.旱期诊断是改善预后的关键。 Objective To investigate the clinical characteristics of 31 patients suffering from ANCA associated vaseulitis (AAV). Methods The clinical data of 31 patients with ANCA positive profiles diagnosed as AAV were analyzed ,including ANCA spectrum,renal and other organs' clinical features. Results There were 16 males and 15 females,average admission age (54. 19 ±20. 00) years( 18 to 84 years). Totally 27 MPA and 4 WG were diagnosed;onset symptoms of renal involvement were in 15 cases and others in 16 cases;18 patients had respiratory system involvements including 8 cases with pulmonary hemorrhage. In admission 27 MPA patients with average SCr (460.42 ± 354. 55 ) μmol/L,and WG group with (659. 62± 535.1 ) μmol/L. ANCA spectrum showed 24 P-ANCA cases and 7 C-ANCA cases, while ELISA method showed 25 anti-MPO cases and 6 anti-PR3 cases. Conclusion AAV has many kinds of manifestations and progresses in many variable ways. Kidney and respiratory system are most vulnerable in AAV. The treatment is very limited in advanced stage of AAV. The key to improving the outcome of AAV is early detection of ANCA and early diagnosis.
出处 《中国实用内科杂志》 CAS CSCD 北大核心 2008年第10期850-852,共3页 Chinese Journal of Practical Internal Medicine
关键词 ANCA相关性血管炎 肾损害 血浆置换 ANCA-associated vasculitis renal involvement plasmopheresis
  • 相关文献

参考文献8

二级参考文献64

  • 1胡伟新,刘春蓓,唐政,俞雨生,王庆文,陈惠萍,刘志红,黎磊石.微型多血管炎肾损害的预后[J].肾脏病与透析肾移植杂志,2004,13(5):419-425. 被引量:11
  • 2陈旻,于峰,张颖,赵明辉.426例抗中性粒细胞胞浆抗体相关性小血管炎患者多系统临床表现和肾脏病理分析[J].中华内科杂志,2005,44(11):828-831. 被引量:65
  • 3Haubitz M, Schellong S, Gobel U,et al. Intravenous pulse administration of cyclophosphamide versus daily oral treatment in patients with antineutrophil cytoplasmic antibody-associated vasculitis and renal involvement : a prospective, randomized study [ J ]. Arthritis Rheum ,1998,41 (10) :1835 - 1844.
  • 4De Groot K,Jayne CRW,Tesar V,et al. Randomised controlled trial of daily oral versus pulse cyclophosphamide for induction of remission in ANCA-associated systemic vasculitis[ J ]. Kidney Blood Press Res,2005,28:195.
  • 5Stassen PM, Cohen Tervaert JW, Stegeman CA. Induction of remission in active ANCA-associated vasculitis with mycophenolate mofetil in patients who cannot be treated with cyclophosphamide[ J]. Ann Rheum Dis,2007,66 ( 6 ) :798 - 802.
  • 6Guillevin L, Cohen P,Mahr A, et al. Treatment of polyarteritis nodosa and microscopic polyangiitis with poor prognosis factors: a prospective trial comparing glucocorticoids and six or twelve cyclophosphamide pulses in sixty-five patients [ J ]. Arthritis Rheum, 2003,49( 1 ) :93 - 100.
  • 7Jayne D, Rasmussen N, Andrassy K, et al. A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies [ J ]. N Engl J Med, 2003,349 ( 1 ) : 36 -44.
  • 8Sanders JS, Slot MC, Stegeman CA. Maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies[J]. N Engl J Med,2003,349(21 ) :2072 -2073.
  • 9Nowack R, Gobel U, Klooker P, et al. Mycophenolate mofetil for maintenance therapy of Wegener's granulomatosis and microscopic polyangiitis: a pilot study in 11 patients with renal involvement [J]. J Am Soc Nephrol,1999,10(9) :1965 - 1971.
  • 10Langford CA,Talar-Williams C, Sneller MC. Mycophenolate mofetil for remission maintenance in the treatment of Wegener's granulomatosis[ J]. Arthritis Rheum,2004,51 (2) :278 - 283.

共引文献123

同被引文献15

  • 1赵明辉,陈旻.小血管炎肾损害[J].中国实用内科杂志,2006,26(3):333-336. 被引量:43
  • 2Jennette JC,Falk RJ,Andrassy K,et al.Nomenclature of systemic vasculitides:Proposal of an international consensus conference.Arthritis Rheum,1994,37(2):187-192.
  • 3Gibson A,Stamp LK,Chapman PT,et al.The epidemiology of Wegeners granulomatosis and microscopic polyangiitis in a Southern Hemisphere region.Rheumatology,2006,45(5):624-628.
  • 4Seo PS,John H.The antineutrophil cytoplasmic antibody-associated vasculitides.Am J Med,2004,117(1):39-50.
  • 5Tanya Pankhurst,Caroline Savage.Pathogenic role of anti-neutrophil cytoplasmic antibodies in vasculitis.Current Opinion in Pharmacology,2006,6(2):190-196.
  • 6Haas M,Eustace JA.Immune complex deposits in ANCA-associated crescentic glomerulonephritis:a study of 126 cases.Kidney Int,2004,65(6):2145-2152.
  • 7Thickett DR,Richter AG,Nathani N,et al.Pulmonary manifestations of Anti-neutrophil cytoplasmic antibody(ANCA)-positive vasculitis.Rheumatology,2006,45(3):261-268.
  • 8Hellmich Bemhard,Lamprecht Peter,Gross Wolfgang.Advances in the therapy of Wegeners granulomatosis.Current Opinion in Rheumatology,2006,18(1):25-32.
  • 9于峰,陈旻,赵明辉.免疫抑制剂在原发性小血管炎治疗中的应用[J].中国实用内科杂志,2008,28(5):331-334. 被引量:11
  • 10王晓华,胡惠民,高翔,叶朝阳,赵学智,梅长林.显微镜下多血管炎22例临床病理分析[J].中国中西医结合肾病杂志,2009,10(4):323-325. 被引量:4

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部